NASDAQ:RGC | Free Cash Flow | Regencell Bioscience Holdings Ltd

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-06-30 to 2025-06-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-06-30-$3.11M$152,689.00-$3.27M
2024-06-30-$4M$5,376.00-$4.01M
2023-06-30-$4.96M$27,392.00-$4.99M
2022-06-30-$5.27M$780,876.00-$6.05M
2021-06-30-$767,311.00
2020-06-30-$726,573.00$117,837.00-$844,410.00
2019-06-30-$390,990.00